Chi Shu

673 total citations
20 papers, 470 citations indexed

About

Chi Shu is a scholar working on Oncology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chi Shu has authored 20 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chi Shu's work include Gestational Diabetes Research and Management (3 papers), Pregnancy and preeclampsia studies (2 papers) and Blood properties and coagulation (2 papers). Chi Shu is often cited by papers focused on Gestational Diabetes Research and Management (3 papers), Pregnancy and preeclampsia studies (2 papers) and Blood properties and coagulation (2 papers). Chi Shu collaborates with scholars based in China, United Kingdom and United States. Chi Shu's co-authors include Xuelei Ma, Fengtian Wang, Lei Liu, Jing Zhang, Yu Jiang, Min Zhou, Yaxiong Sang, Yazhou He, Wuning Zhong and Shaoping Deng and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Journal of Clinical Epidemiology.

In The Last Decade

Chi Shu

20 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Shu China 10 166 112 92 79 73 20 470
Hannah Lennon United Kingdom 4 232 1.4× 101 0.9× 50 0.5× 24 0.3× 99 1.4× 6 655
Christopher Gilfillan Australia 14 106 0.6× 97 0.9× 61 0.7× 21 0.3× 87 1.2× 35 600
Sophie Léobon France 13 308 1.9× 84 0.8× 64 0.7× 17 0.2× 87 1.2× 30 502
Charlotte Burmeister United States 14 86 0.5× 110 1.0× 35 0.4× 171 2.2× 69 0.9× 46 456
J. Schmucker-Von Koch Germany 6 389 2.3× 118 1.1× 106 1.2× 17 0.2× 181 2.5× 10 618
Y Lehingue France 8 156 0.9× 162 1.4× 129 1.4× 27 0.3× 56 0.8× 18 895
Volker Ziller Germany 17 421 2.5× 90 0.8× 200 2.2× 73 0.9× 65 0.9× 55 1.1k
Paul Y. Song United States 7 57 0.3× 60 0.5× 29 0.3× 40 0.5× 223 3.1× 26 705
Meghan A. Cupp United States 6 247 1.5× 79 0.7× 23 0.3× 22 0.3× 100 1.4× 17 480
Miranda J.M. Dirx Netherlands 14 454 2.7× 188 1.7× 109 1.2× 25 0.3× 423 5.8× 18 1.0k

Countries citing papers authored by Chi Shu

Since Specialization
Citations

This map shows the geographic impact of Chi Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Shu more than expected).

Fields of papers citing papers by Chi Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Shu. The network helps show where Chi Shu may publish in the future.

Co-authorship network of co-authors of Chi Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Shu. A scholar is included among the top collaborators of Chi Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Shu. Chi Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shu, Chi, et al.. (2025). Cardiovascular disease risk in cancer survivors: a population-based cohort study from the UK Biobank, and meta-analysis of cohort studies. BMJ Public Health. 3(1). e001303–e001303. 1 indexed citations
2.
3.
Shu, Chi, Hong Li, Hong Wu, et al.. (2025). Cancer risk subsequent to cardiovascular disease: a prospective population-based study and meta-analysis. BMC Medicine. 23(1). 192–192. 3 indexed citations
4.
Shu, Chi, Qian Yang, Jun Huang, et al.. (2024). Pretreatment plasma vitamin D and response to neoadjuvant chemotherapy in breast cancer: evidence from pooled analysis of cohort studies. International Journal of Surgery. 110(12). 8126–8135. 7 indexed citations
5.
Shu, Chi, Xiran Wang, Changtao Li, et al.. (2024). Revisiting the association between pretreatment thrombocytosis and cancer survival outcomes: an umbrella review of meta-analyses. BMC Cancer. 24(1). 1246–1246. 2 indexed citations
6.
Wu, Qingbin, Pengju Chen, Chi Shu, et al.. (2023). Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts. BMC Medicine. 21(1). 3–3. 8 indexed citations
7.
Zhou, Yiling, Nan Li, Xiangyang Chen, et al.. (2022). Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes. Cardiovascular Diabetology. 21(1). 290–290. 51 indexed citations
8.
Shu, Chi, Bin Huang, Ding Yuan, et al.. (2021). Surgical clinical trials with non-inferiority design: a cross-sectional bibliometric analysis. Annals of Translational Medicine. 9(16). 1302–1302. 1 indexed citations
9.
He, Yazhou, Chi Shu, Ting Li, et al.. (2021). Non-inferiority in cancer clinical trials was associated with more lenient margins and higher hypothesized outcome event rates. Journal of Clinical Epidemiology. 139. 214–221. 2 indexed citations
10.
Zhu, Ying, Jie Zhou, Yi Feng, et al.. (2018). Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2. Frontiers in Immunology. 9. 87–87. 37 indexed citations
11.
Shu, Chi, Zhoupeng Wu, Jichun Zhao, et al.. (2017). Percutaneous Vascular Interventions Versus Bypass Surgeries in Patients With Critical Limb Ischemia. Annals of Surgery. 267(5). 846–857. 10 indexed citations
12.
Wang, Jiarong, Yazhou He, Chi Shu, Jichun Zhao, & Luc Dubois. (2017). The effect of gender on outcomes after lower extremity revascularization. Journal of Vascular Surgery. 65(3). 889–906.e4. 31 indexed citations
13.
14.
Shu, Chi, et al.. (2016). Epstein–Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma. Medicine. 95(40). e5130–e5130. 46 indexed citations
15.
Liao, Shunyao, Yunqiang Liu, Xiaojuan Chen, et al.. (2015). The Impact of Genetic Variants for Different Physiological Characterization of Type 2 Diabetes Loci on Gestational Insulin Signaling in Nondiabetic Pregnant Chinese Women. Reproductive Sciences. 22(11). 1421–1428. 11 indexed citations
16.
Shu, Chi, et al.. (2015). Effects of interleukin 10 polymorphisms on the development of hepatitis B virus infection: a systemic review and meta-analysis.. PubMed. 8(8). 12028–40. 3 indexed citations
17.
Wang, Jiarong, Chengdi Wang, Nan Chen, et al.. (2014). Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: A meta-analysis. Thrombosis Research. 134(6). 1241–1248. 29 indexed citations
18.
Ma, Xuelei, Jing Zhang, Wuning Zhong, et al.. (2014). The diagnostic role of a short screening tool—the distress thermometer: a meta-analysis. Supportive Care in Cancer. 22(7). 1741–1755. 144 indexed citations
19.
20.
Liao, Shunyao, Yunqiang Liu, Yuan-De Tan, et al.. (2012). Association of Genetic Variants of Melatonin Receptor 1B with Gestational Plasma Glucose Level and Risk of Glucose Intolerance in Pregnant Chinese Women. PLoS ONE. 7(7). e40113–e40113. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannah Lennon Breakdown of academic impact, for papers by Christopher Gilfillan Breakdown of academic impact, for papers by Sophie Léobon Breakdown of academic impact, for papers by Charlotte Burmeister Breakdown of academic impact, for papers by J. Schmucker-Von Koch Breakdown of academic impact, for papers by Y Lehingue Breakdown of academic impact, for papers by Volker Ziller Breakdown of academic impact, for papers by Paul Y. Song Breakdown of academic impact, for papers by Meghan A. Cupp Breakdown of academic impact, for papers by Miranda J.M. Dirx
Rankless by CCL
2026